Onego Bio, a Finnish-U.S. food ingredient company, announced the submission of its Generally Recognized as Safe (GRAS) notification to the U.S. Food and Drug Administration (FDA) for its non-animal ovalbumin, produced through precision fermentation using Trichoderma reesei, and branded as Bioalbumen®.

The 5,000-square-foot facility will serve as the company’s U.S. commercial headquarters, housing office space alongside a state-of-the-art test kitchen and cutting-edge quality lab facilities.

Onego Bio, the producer of Bioalbumen®, has been awarded $2 million in funding from the United States Department of Defense’s (DoD’s) Distributed Bioindustrial Manufacturing Program (DBIMP). The funding from this program supports the advancement of biomanufacturing infrastructure across the United States, strengthening the domestic supply of key materials and ingredients. 

Onego Bio secures €14M / $15.2M new funding to advance animal-free egg protein production.

An industry disruptor, Onego Bio, has completed Series A funding round – one of the largest in the Nordics - for scaling its revolutionary animal-free egg protein, Bioalbumen®

The world deserves a way to produce our beloved egg protein without the hefty burden of animal agriculture – luckily, we know a better way. Read more how we cracked the code to produce animal-free egg protein!

Fast Company Magazine has named Bioalbumen™ the 2023 winner of the Food category and a Finalist in the Agriculture category.

Leading precision fermentation players have come together to establish a new alliance, Food Fermentation Europe (FFE), that will work towards a forward looking regulatory environment that can help bring more sustainable animal-free foods and ingredients to the European market and enable a resilient and sustainable food system in Europe.

Onego Bio is proud to be one of the founders of Precision Fermentation Alliance and join forces with Perfect Day, Change Foods, Remilk, New Culture, Motif FoodWorks, Imagindairy, Every and Helaina to champion a more resilient and sustainable food system.

What an impactful first year it has been! We made great progress in our award-winning precision fermentation technology, set up capabilities to produce animal-free egg white, won 9 awards, our talented team of gamechangers grew to 19.. Next we continue to build our team and relationships with key global partners that drive our mission forward and speed us towards launching our first product, Bioalbumen®.

Global biotechnology leader Perfect Day announces the new brand identity of its enterprise biology business — nth Bio — and its first publicly-announced partner, Onego Bio Ltd

With the new funding granted by Business Finland, the company can accelerate the research and development of animal-free egg white production even further. The company’s solution rises to the major global challenges of food production and sustainable development.

Finnish startup Onego Bio Ltd raises EUR 10M in seed funding to commercialize a breakthrough technology to produce egg white without chickens